Home » Topics » Regulatory

Regulatory
RSS

E.U. approval for Avonex for early use in high-risk MS patients

May 21, 2002

Actonel 35 mg approved for once-weekly dosing in postmenopausal osteoporosis

May 21, 2002

Paxil approved in Canada for posttraumatic stress disorder

May 17, 2002

Tacrolimus for psoriasis scheduled for marketing within three to four years

May 10, 2002

Positive pharmacokinetic results for buccal desmopressin

May 10, 2002

IND submitted for nitroglycerin lingual spray

May 10, 2002

Avalox i.v. cleared for market introduction in Germany

May 8, 2002

Protonix delayed-release tablets approved for long-term treatment of Zollinger-Ellison syndrome

May 7, 2002

Generex completes proof-of-concept study for buccal fentanyl citrate

May 6, 2002

Sheffield and Inhale to develop inhaled migraine therapy

May 6, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...